These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 9795300

  • 1. [Treatment of pneumonia caused by Legionella with azithromycin].
    Sánchez F, Mensa J, Martínez JA, Badia R, Albarracín M, Losa JE, Ruiz M, Marcos MA, Torres A, Soriano E.
    Rev Esp Quimioter; 1998 Jun; 11(2):147-51. PubMed ID: 9795300
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.
    Griffin AT, Peyrani P, Wiemken T, Arnold F.
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy.
    Mykietiuk A, Carratalà J, Fernández-Sabé N, Dorca J, Verdaguer R, Manresa F, Gudiol F.
    Clin Infect Dis; 2005 Mar 15; 40(6):794-9. PubMed ID: 15736010
    [Abstract] [Full Text] [Related]

  • 6. Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study.
    Kuzman I, Soldo I, Schönwald S, Culig J.
    Scand J Infect Dis; 1995 Mar 15; 27(5):503-5. PubMed ID: 8588143
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Legionellosis.
    Pedro-Botet ML, Sabrià M.
    Semin Respir Crit Care Med; 2005 Dec 15; 26(6):625-34. PubMed ID: 16388431
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A Case of Community-Acquired Pneumonia Due to Legionella pneumophila Serogroup 9 Wherein Initial Treatment with Single-Dose Oral Azithromycin Appeared Useful.
    Ito A, Ishida T, Tachibana H, Ito Y, Takaiwa T, Fujii H, Hashimoto T, Nakajima H, Amemura-Maekawa J.
    Jpn J Infect Dis; 2017 Nov 22; 70(6):660-662. PubMed ID: 28890505
    [Abstract] [Full Text] [Related]

  • 12. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.
    Nakamura S, Yanagihara K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Senjyu H, Saito A, Kohno S.
    J Infect; 2009 Sep 22; 59(3):222-4. PubMed ID: 19592113
    [No Abstract] [Full Text] [Related]

  • 13. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?
    Sánchez F, Mensa J, Martínez JA, García E, Marco F, González J, Marcos MA, Soriano A, Torres A.
    Clin Infect Dis; 2003 May 15; 36(10):1239-45. PubMed ID: 12746768
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
    Bartlett JG.
    Clin Infect Dis; 2008 Dec 01; 47 Suppl 3():S232-6. PubMed ID: 18986295
    [Abstract] [Full Text] [Related]

  • 16. [Treatment for Legionnaires' disease. Macrolides or quinolones?].
    Falcó V, Molina I, Juste C, Crespo M, Almirante B, Pigrau C, Ferrer A, Bravo C, Palomar M, Pahissa A.
    Enferm Infecc Microbiol Clin; 2006 Dec 01; 24(6):360-4. PubMed ID: 16792936
    [Abstract] [Full Text] [Related]

  • 17. Legionnaires disease with bacteremic coinfection.
    Tan MJ, Tan JS, File TM.
    Clin Infect Dis; 2002 Sep 01; 35(5):533-9. PubMed ID: 12173126
    [Abstract] [Full Text] [Related]

  • 18. Severe community-acquired pneumonia due to Legionella pneumophila Serogroup 6.
    Chen CY, Chen KY, Hsueh PR, Yang PC.
    J Formos Med Assoc; 2006 Mar 01; 105(3):256-62. PubMed ID: 16520845
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens.
    Dunbar LM, Khashab MM, Kahn JB, Zadeikis N, Xiang JX, Tennenberg AM.
    Curr Med Res Opin; 2004 Apr 01; 20(4):555-63. PubMed ID: 15119993
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic, therapeutic and economic consequences of a positive urinary antigen test for Legionella spp. in patients admitted with community-acquired pneumonia: a 7-year retrospective evaluation.
    Engel MF, van Manen L, Hoepelman AI, Thijsen S, Oosterheert JJ.
    J Clin Pathol; 2013 Sep 01; 66(9):797-802. PubMed ID: 23775436
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.